Abstract
Increasingly, policymakers within biomedicine argue that “non-financial” interests should be given equal scrutiny to individuals’ financial relationships with industry. Problematized as “non-financial conflicts of interest,” interests, ranging from intellectual commitments to personal beliefs, are managed through disclosure, restrictions on participation, and recusal where necessary. “Non-financial” interests, though vaguely and variably defined, are characterized as important influences on judgment and thus, are considered risks to scientific objectivity. This article explores the ways that “non-financial interests” have been constructed as an ethical problem and the implications for research integrity. I conducted an interpretive, qualitative study, which triangulated two data sources: documents (including published accounts of identifying and managing “non-financial” interests and conflict of interest policies) and in-depth interviews with 16 leaders within evidence-based medicine, responsible for contributing to, directing, or overseeing conflict of interest policy development and implementation. This article outlines how evolutions in the definition of conflict of interest have opened the door to include myriad “non-financial” interests, resulting in the generalisation of a statistical concept—risk of bias—to social contexts. Consequently, biases appear equally pervasive among participants while in reality, a politics of objectivity is at play, with allegations of conflict of interest used as a means to undermine others’ credibility, or even participation. Iterations of the concept of conflict of interest within biomedicine have thus consistently failed to articulate or address questions of accountability including whose interests are able to dominate or distort evidence-led processes and why. Consequently, current policy solutions meant to mitigate bias may instead serve exclusionary purposes under the guise of impartiality while remaining vulnerable to interference from powerful stakeholders.
Similar content being viewed by others
Data Availability
The transcripts are not available per the ethics approval and participants’ consent.
References
Akl, E. A., El-Hachem, P., Abou-Haidar, H., et al. (2014). Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: A descriptive study. Journal of Clinical Epidemiology, 67(11), 1222–1228.
Akl, E. A., Karl, R., & Guyatt, G. H. (2012). Methodologists and context experts disagreed regarding managing conflicts of interest of clinical practice guidelines panels. Journal of Clinical Epidemiology, 65(7), 734–739.
Anderson, E. (2004). Use of value judgments in Science: A general argument, with lessons from a case study of feminist research on divorce. Hypatia, 19(1), 1–24.
Benner, P., Tanner, C., & Chesla, C. (2009). Background and method. In P. Benner, C. Tanner, & C. Chesla (Eds.), Expertise in nursing practice: Caring, clinical judgment and ethics (pp. 351–372). Springer.
Bero, L. A. (2013). Why the Cochrane risk of bias tool should include funding source as a standard item. Cochrane database of systematic reviews (12), ED000075.
Borgerson, K. (2009). Valuing evidence: Bias and the evidence hierarchy of evidence-based medicine. Perspectives in Biology and Medicine, 52(2), 218–233.
Chalmers, I. (1983). Scientific inquiry and authoritarianism in perinatal care and education. Birth, 10(3), 151–166.
Chren, M. M., & Landefeld, C. S. (1994). Physicians’ behavior and their interactions with drug companies: A controlled study of physicians who requested additions to a hospital drug formulary. Journal of the Americal Medical Association, 271(9), 684–689.
Djulbegovic, B., Guyatt, G. H., & Ashcroft, R. E. (2009). Epistemologic inquiries in evidence-based medicine. Cancer Control, 16(2), 158–168.
Goldenberg, M. J. (2006). On evidence and evidence-based medicine: Lessons from the philosophy of science. Social Sciences and Medicine, 62(11), 2621–2632.
Goldenberg, M. J. (2015). How can feminist theories of evidence assist clinical reasoning and decision-making? Social Epistemology, 29(1), 3–30.
Greenfield, S. (2018). Guideline recommendations for preventive healthcare services: Understanding and managing conflict of interest when population health meets personalized medicine. American Journal of Preventive Medicine, 54(1), 153–155.
Grundy, Q., Mazzarello, S., & Bero, L. (2020a). A comparison of policy provisions for managing “financial” and “non-financial” interests across health-related research organizations: A qualitative content analysis. Accountability in Research, 27(4), 212–237.
Grundy Q, Mayes C, Holloway K, et al. (2020b). Conflict of interest as ethical shorthand: understanding the range and nature of “non-financial conflict of interest” in biomedicine. Journal of Clinical Epidemiology, 120, 1–7.
Guyatt, G., Akl, E. A., Hirsh, J., et al. (2010). The vexing problem of guidelines and conflict of interest: A potential solution. Annals of Internal Medicine, 152(11), 738–741.
Guyatt, G., Cairns, J., Churchill, D., et al. (1992). Evidence-based medicine: A new approach to teaching the practice of medicine. Journal of the Americal Medical Association, 268(17), 2420–2425.
Haraway, D. (1997). Modest_Witness@Second_Millennium. FemaleMan_Meets_OncoMouseTM. New York, NY: Routledge.
Harding, S. (1992). Whose science? Whose knowledge?: Thinking from women’s lives. Cornell University Press.
Hill Collins, P. (1989). The social construction of black feminist thought. Signs: Journal of Women in Culture and Society, 14(4), 745–773.
Intemann, K. (2010). 25 years of feminist empiricism and standpoint theory: Where are we now? Hypatia, 25, 778–796.
Intemann, K., & de Melo-Martín, I. (2016). Feminist values, commercial values, and the bias paradox in biomedical research. In M. C. Amoretti & N. Vassallo (Eds.), Meta-Philosophical reflection on feminist philosophies of science (pp. 75–89). Switzerland: Springer International Publishing.
International Epidemiological Association. (2001). A dictionary of epidemiology. Oxford University Press.
Ioannidis, J. A., & Trepanowski, J. F. (2018). Disclosures in nutrition research: Why it is different. Journal of the Americal Medical Association, 319(6), 547–548.
Kassirer, J. P., & Angell, M. (1993). Financial conflicts of interest in biomedical research. New England Journal of Medicine, 329(8), 570–571.
Lexchin, J. (1993). Physicians and drug companies interact. Canadian Family Physician, 39, 1881–1882.
Lexchin, J., Bero, L. A., Djulbegovic, B., et al. (2003). Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. British Medical Journal, 326, 1167–1170.
Leykin, Y., & DeRubeis, R. J. (2009). Allegiance in psychotherapy outcome research: Separating association from bias. Clinical Psychology: Science and Practice, 16, 54–65.
Lo, B., & Field, M. J. (2009). Conflict of interest in medical research, education and practice. The Institute of Medicine National Academies Press.
Luborsky, L., Diguer, L., Seligman, D. A., et al. (1999). The researcher’s own therapy allegiances: A “wild card” in comparisons of treatment efficacy. Clinical Psychology: Science and Practice, 6(1), 95–106.
Luborsky, L., Singer, B., & Luborsky, L. (1975). Comparative studies of psychotherapies: Is it true that “everyone has won and all must have prizes”? Archives of General Psychiatry, 32(8), 995–1008.
Mrdjenovich, A. J. (2020). Authors disclosing their theistic orientation in journal articles on religion and health? Infrequent, informal, and mostly inconsistent with conflict of interest. Journal of Religion and Health, 59(2), 651–680.
National Academies of Science. (2005). Getting to know the committee process. The National Academies.
Neill, S., Martin, L., & Harris, L. (2020). Is clinical expertise a conflict of interest in research? Women’s Health, 16, 1–7.
Ngo-Metzger, Q., Moyer, V., Grossman, D., et al. (2018). Conflicts of interest in clinical guidelines: Update of U.S. preventive services task force policies and procedures. American Journal of Preventive Medicine, 54(1), S70–S80.
Nissen, S. E. (2017). Conflicts of interest and professional medical associations: Progress and remaining challenges. Journal of the Americal Medical Association, 317(17), 1737–1738.
Norris, S. L., Burda, B. U., Holmer, H. K., et al. (2012). Author’s specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. Journal of Clinical Epidemiology, 65(7), 725–733.
Norris, S. L., Holmer, H. K., Ogden, L. A., et al. (2011). Conflict of interest in clinical practice guideline development: A systematic review. PLoS ONE, 6(10), e25153.
Qaseem, A., & Wilt, T. J. (2019). Disclosure of interests and management of conflicts of interest in clinical guidelines and guidance statements: Methods from the clinical guidelines committee of the American college of physicians. Annals of Internal Medicine, 171(5), 354–361.
Relman, A. S. (1980). The new medical-industrial complex. New England Journal of Medicine, 303(17), 963–970.
Relman, A. S. (1984). Dealing with conflicts of interest. New England Journal of Medicine, 310(18), 1182–1183.
Relman, A. S. (1990). New information for authors—and readers. New England Journal of Medicine, 323(1), 56–56.
Rogers, W. (2004). Evidence-based medicine and women: Do the principles and practice of EBM futher women’s health? Bioethics, 18(1), 50–71.
Sackett, D. (1982). Proposals for the health science—I. Compulsory retirement for experts. Journal of Chronic Diseases, 36(7), 545–547.
Schünemann, H. J., Al-Ansary, L. A., Forland, F., et al. (2015). Guidelines international network: Principles for disclosure of interests and management of conflicts in guidelines. Annals of Internal Medicine, 163(7), 548–553.
Smith, R., & Blazeby, J. (2018). Why religious belief should be declared as a competing interest. British Medical Journal, 361, k1456.
Sniderman, A. D., & Furberg, C. D. (2012). Pluralism of viewpoints as the antidote to intellectual conflict of interest in guidelines. Journal of Clinical Epidemiology, 65(7), 705–707.
Sterne, J. A. C. (2013). Why the Cochrane risk of bias tool should not include funding source as a standard item. Cochrane Database of Systematic Reviews, 12, ED000075.
TallBear, K. (2019). Feminist, queer, and indigenous thinking as an antidote to masculinist objectivity and binary thinking in biological anthropology. American Anthropologist, 121, 494–496.
Thompson, D. (1993). Understanding financial conflicts of interest. New England Journal of Medicine, 329(8), 573–573.
Timmermans, S., & Berg, M. (2003). The gold standard: The challenge of evidence-based medicine and standardization in health care. Temple University Press.
Viswanathan, M., Carey, T. S., Belinson, S. E., et al. (2014). A proposed approach may help systematic reviews retain needed expertise while minimizing bias from nonfinancial conflicts of interest. Journal of Clinical Epidemiology, 67, 1229–1238.
Wazana, A. (2000). Physicians and the pharmaceutical industry: Is a gift ever just a gift? Journal of the Americal Medical Association, 283, 373–380.
Wiersma, M., Kerridge, I., Lipworth, W., et al. (2018). Should we try to manage non-financial interests? British Medical Journal, 361, k1240.
Funding
This work was supported through a Postdoctoral Fellowship from the Canadian Institutes of Health Research and a Connaught New Researcher Award from the University of Toronto.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares there is no conflict of interest.
Ethical Approval
This research was approved by The University of Sydney and University of Toronto Health Research Ethics Boards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Grundy, Q. A Politics of Objectivity: Biomedicine’s Attempts to Grapple with “non-financial” Conflicts of Interest. Sci Eng Ethics 27, 37 (2021). https://doi.org/10.1007/s11948-021-00315-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11948-021-00315-8